Skip to content
10-Q

Quarterly Report

CAMP4 Therapeutics Corporation CAMP

0001628280-26-032146

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 51.93M sh
Shares Diluted Q1 2026 · Mar 31, 2026 57.92M sh
Shares Diluted Q1 2026 · Mar 31, 2025 20.15M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $279K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$10.98M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$14.29M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $99.21M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $109.52M
Stockholders Equity Q1 2026 · Mar 31, 2026 $30.9M
Stockholders Equity Q1 2026 · Dec 31, 2025 $47.7M
Stockholders Equity Q1 2026 · Mar 31, 2025 $51.57M
Stockholders Equity Q1 2026 · Dec 31, 2024 $63.14M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.62M
Current Liabilities Q1 2026 · Dec 31, 2025 $15.51M
Total Liabilities Q1 2026 · Mar 31, 2026 $74.56M
Total Liabilities Q1 2026 · Dec 31, 2025 $70.1M
Current Assets Q1 2026 · Mar 31, 2026 $102.2M
Current Assets Q1 2026 · Dec 31, 2025 $114.1M
Total Assets Q1 2026 · Mar 31, 2026 $105.46M
Total Assets Q1 2026 · Dec 31, 2025 $117.81M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.62
Eps Basic Q1 2026 · Mar 31, 2026 −$0.32
Eps Basic Q1 2026 · Mar 31, 2025 −$0.62
Sga Expense Q1 2026 · Mar 31, 2026 $4.21M
Sga Expense Q1 2026 · Mar 31, 2025 $3.81M
Rd Expense Q1 2026 · Mar 31, 2026 $10.16M
Rd Expense Q1 2026 · Mar 31, 2025 $10.15M
Net Income Q1 2026 · Mar 31, 2026 −$18.33M
Net Income Q1 2026 · Mar 31, 2025 −$12.43M
Operating Income Q1 2026 · Mar 31, 2026 −$13.07M
Operating Income Q1 2026 · Mar 31, 2025 −$13.1M